Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 26 March 2018 |
| Author/s |
author: Svetislava J Vukelja Kristi J McIntyre Lina Asmar John E Pippen Joyce O'Shaughnessy Frankie Ann Holmes Joanne L Blum |
| Publication date | March 26, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |